Cardio Diagnostics
CDIO
23 hedge funds and large institutions have $2.36M invested in Cardio Diagnostics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
531% more capital invested
Capital invested by funds: $374K → $2.36M (+$1.98M)
53% more funds holding
Funds holding: 15 → 23 (+8)
0.12% less ownership
Funds ownership: 6.48% → 6.36% (-0.12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$119K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$83.2K |
| 3 |
HF
HRT Financial
New York
|
+$66.7K |
| 4 |
Jane Street
New York
|
+$52K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$30.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CSC
Caldwell Sutter Capital
Sausalito,
California
|
-$1.81K |
CDIO Hedge Fund Activity: Q4 2024 in Review
23 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q4 2024, worth a combined $2.36M — up 531% from $374K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CDIO positions and 1 closed out — a net gain of 8 holders — while 7 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $119K. The largest seller was Caldwell Sutter Capital, exiting entirely with an estimated $1.81K sold.
- 23 institutional investors held Cardio Diagnostics (CDIO) as of Q4 2024, up from 15 in Q3 2024.
- Funds reported $2.36M of Cardio Diagnostics stock for Q4 2024, up 531% quarter-over-quarter.
- 9 funds opened new Cardio Diagnostics positions in Q4 2024 and 1 closed out, a net change of +8 holders.
- The largest Cardio Diagnostics buyer in Q4 2024 was Millennium Management, an estimated $119K added.
- The largest Cardio Diagnostics seller in Q4 2024 was Caldwell Sutter Capital, an estimated $1.81K sold.
Based on aggregated 13F filings for Q4 2024.